| Manjari Gambhir Malkani, MD | |
|
1221 N Highland Ave, Aurora, IL 60506-1404 | |
| (630) 859-8700 | |
| Not Available |
| Full Name | Manjari Gambhir Malkani |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 27 Years |
| Location | 1221 N Highland Ave, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467410183 | NPI | - | NPPES |
| 036109834 | Medicaid | IL | |
| 200916150 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 01065017A (Indiana) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 036109834 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Dupage Hospital | Winfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Dupage Physician Group | 5890696231 | 1003 |
| Rush University Medical Center | 5496658874 | 1007 |
News Archive
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Future Science Group has launched Future Science Open, the publisher's first fully open access journal. Each month, Future Science Open will publish research in all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are relevant to human health.
› Verified 2 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Future Science Group has launched Future Science Open, the publisher's first fully open access journal. Each month, Future Science Open will publish research in all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are relevant to human health.
› Verified 2 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Future Science Group has launched Future Science Open, the publisher's first fully open access journal. Each month, Future Science Open will publish research in all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are relevant to human health.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manjari Gambhir Malkani, MD 2357 Sequoia Dr, Aurora, IL 60506-6222 Ph: (630) 859-6800 | Manjari Gambhir Malkani, MD 1221 N Highland Ave, Aurora, IL 60506-1404 Ph: (630) 859-8700 |
News Archive
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Future Science Group has launched Future Science Open, the publisher's first fully open access journal. Each month, Future Science Open will publish research in all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are relevant to human health.
› Verified 2 days ago
Dr. Simi Susan Rodney, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-892-4355 | |
Dr. Savitha Allam, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 866-565-8607 Fax: 630-898-3427 | |
Dr. Sharon C Ollee, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4100 Healthway Dr, Aurora, IL 60504 Phone: 630-851-3105 | |
Anne M Kinn, DO Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-801-2678 | |
Dr. Nidhi Tiwari, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2020 Ogden Ave Ste 400, Aurora, IL 60504 Phone: 630-692-5563 Fax: 630-692-5564 | |
Priyadarshini Verma, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 | |
Dr. Ravi K Prakash, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1221 N Highland Ave, Aurora, IL 60506 Phone: 630-859-8700 |